| SPRO Stock Yearly Return 2023 Table | ||||||||||||||||||||||||||||||
SPRO average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| Average Annual Return Benchmarks |
|
Compare SPRO average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| SPRO Share Performance |
| SPRO Stock Yearly Return 2023 Chart | |||
Also see: • SPRO YTD return • SPRO average annual return 10 years | |||
| About Spero Therapeutics Inc |
| Spero Therapeutics is a biopharmaceutical company focused on identifying, developing, and commercializing treatments involving bacterial infections. Co.'s product candidate, SPR720, is an oral antimicrobial agent in development for the treatment of nontuberculous mycobacterial pulmonary disease. Co.'s partnership-directed programs consist of tebipenem pivoxil hydrobromide, which is designed to be oral carbapenem-class antibiotic for use to treat certain bacterial infections that cause complicated urinary tract infections; and SPR206, which is an IV-administered antibiotic being developed as an option to treat multi-drug resistant Gram-negative bacterial infections in the hospital setting. The SPRO stock yearly return is shown above.
The yearly return on the SPRO stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2023 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon. One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the SPRO annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| SPRO Current Stock Quote |
 Free SPRO Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Annual Return! | |
|
| Yearly Return Peers |
| Spero Therapeutics (SPRO) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
SPRY Average Annual Return |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.
Video: Don't Forget Dividends in Average Annual Return!